file;unicode	channel;int	start;float	end;float	speaker;unicode	speakerType;unicode	speakerDialect;unicode	transcript;unicode	section;int	turn;int	segment;int	sectionType;unicode	suType;unicode
PLA_CMN_20080710.0741	0	0.0	100.0	speaker	unknown	unknown	Treatment of "Severe Lupus Nephritis" Gets Medical Community Excited	0	0	0		
PLA_CMN_20080710.0741	0	400.0	500.0	speaker	unknown	unknown	Li Leishi said: "The therapeutic effect of the multi-target therapy for severe lupus nephritis is far superior to that of traditional therapy and with few side effects."	0	0	0		
PLA_CMN_20080710.0741	0	500.0	600.0	speaker	unknown	unknown	Severe lupus nephritis is internationally acknowledged as a tough problem for treatment. The traditional therapy uses a single application of an immunosuppressant drug; the therapeutic effect is poor, and the mortality rate is high.	0	0	0		
PLA_CMN_20080710.0741	0	800.0	900.0	speaker	unknown	unknown	Since 2003, under Li Leishi's proposal, the Military's Research Institute of Nephrology has carried out extensive exploration in fundamental theories and proposed using multiple immunosuppressant drugs with different targeted effects to treat severe lupus nephritis.	0	0	0		
PLA_CMN_20080710.0741	0	900.0	1000.0	speaker	unknown	unknown	After 2007, the research work on multi-target immunotherapy for severe lupus nephritis was basically complete and a set of treatment plans was formed.	0	0	0		
PLA_CMN_20080710.0741	0	1200.0	1300.0	speaker	unknown	unknown	At the same time, an American medical journal "Med page Today" (Medical News Today) specially published two news releases, giving a detailed introduction to the significance of this research and its therapeutic approaches.	0	0	0		
